Symbol
| DAPK1
| contributors: mct/pgu - updated : 15-11-2019
|
HGNC name
| death-associated protein kinase 1
|
HGNC id
| 2674
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
|  
|  
|
by hypermethylation in head and neck carcinomas | tumoral
|  
|  
| --low
|  
|
by promoter methylation in B cell chronic lymphocytic leukemia and chronic myeloid leukemia (promoter methylation might play a significant role in the progression of CML) | |
Susceptibility
|
to late-onset Alzheimer's disease to chronic lymphocytic leukemia |
Variant & Polymorphism
SNP
| significantly associated with late-onset Alzheimer's disease |
|
downregulation in familial chronic lymphocytic leukemia |
|
|
Candidate gene
| for sensitive detection in plasma or serum of cancer gastric, lung cancer, head and neck cancer, by DNA methylation markers |
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | hemopathy | | |
for the development of novel treatment regimens in chronic lymphocytic leukemia involving epigenetic therapies for gene reactivation | cancer | digestive | liver | |
potential therapeutic targets for HCC |
| | |